Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nomura Holdings Inc ADR (“Nomura” or “the Company”) (NYSE: NMR). Investors who purchased Nomura securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Nomura has violated federal securities laws.
Investigation Details
On September 30, 2024, media outlets reported that Nomura was excluded as lead manager for several yen bond deals after an investigation by Japan’s securities watchdog into suspected market manipulation in government bond futures found rule violations by Nomura. On this news, Nomura’s American depositary receipt (“ADR”) price fell $0.26 per ADR, or 4.74%, to close at $5.22 per ADR on September 30, 2024.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Nomura securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
NMR — Stock Performance
About Bronstein, Gewirtz & Grossman, LLC
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”